Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.

M Koutelou,A Mastorakou,L Lamprakos,A Zissimopoulos,V Prassopoulos,T Chatzipanagiotou,A Doumas

doi:10.1967/s002449912600

Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.

M Koutelou, A Mastorakou + Show 5 more

https://doi.org/10.1967/s002449912600

Copy DOI

Export

Save

Cite

Journal: Hellenic journal of nuclear medicine

Publication Date: Feb 1, 2023

#Cardiac Amyloidosis #Position Statement #Heart Tissue #Amyloids In Tissue #Society Of Cardiology #Accumulation Of Proteins #Nuclear Medicine Practitioners #Accumulation Of Abnormal Proteins #Hellenic Society #Medicine Practitioners

Abstract
Full-Text
Similar Papers

Abstract

Listen

Cardiac amyloidosis is a rare condition characterized by the accumulation of abnormal proteins called amyloids in the heart tissue. These amyloids can disrupt the normal functioning of the heart and lead to a variety of symptoms and complications.

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Hellenic journal of nuclear medicine

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.